Literature DB >> 11745226

A comparison of published head and neck stage groupings in carcinomas of the tonsillar region.

P A Groome1, K M Schulze, W J Mackillop, B Grice, C Goh, B J Cummings, S F Hall, F F Liu, D Payne, D M Rothwell, J N Waldron, P R Warde, B O'Sullivan.   

Abstract

BACKGROUND: The combination of T, N, and M classifications into stage groupings was designed to facilitate a number of activities including: the estimation of prognosis and the comparison of therapeutic interventions among similar groups of cases. The authors tested the UICC/AJCC 5th edition stage grouping and seven other TNM-based groupings proposed for head and neck cancer to determine their ability to meet these expectations in a specific site: carcinoma of the tonsillar region.
METHODS: The authors defined four criteria to assess each stage grouping scheme: 1) The subgroups defined by T and N comprising a given group within a grouping scheme have similar survival rates (hazard consistency); 2) The survival rates differ across the groups (hazard discrimination); 3) The prediction of cure is high (outcome prediction); and 4) The distribution of patients among the groups is balanced. The authors identified or derived a measure for each criterion and the findings were summarized using a scoring system. The range of scores was from 0 (best) to 7 (worst). Data were from a retrospective chart review on 642 cases of carcinoma of the tonsillar region treated with radiotherapy for cure at the Princess Margaret Hospital from 1970-1991. None of the patients had distant metastases.
RESULTS: The scheme proposed by Synderman and Wagner, which was published in Otolaryngology Head and Neck Surgery in 1995 (vol.112, pages 691-4), scored best at 1.2. The UICC/AJCC scheme scored worst at 6.1. The hazard consistency ranged from a 3.1% average survival difference to 6.7% across the 8 schemes. The hazard discrimination measure varied by 28% from the best to worst scheme. Prediction varied by up to almost twofold across the schemes assessed. The distribution of patients varied from expected by between 0.13% and 0.57%.
CONCLUSION: UICC/AJCC stage groupings were defined without empirical investigation. When tested, this scheme did not perform as well as any of seven empirically-derived schemes the authors evaluated. The results of the current study suggest that the usefulness of the TNM system can be enhanced by optimizing the design of stage groupings through empirical investigation. Copyright 2001 American Cancer Society.

Entities:  

Mesh:

Year:  2001        PMID: 11745226     DOI: 10.1002/1097-0142(20010915)92:6<1484::aid-cncr1473>3.0.co;2-w

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  Opportunities and challenges facing biomarker development for personalized head and neck cancer treatment.

Authors:  Alexandra Lucs; Benjamin Saltman; Christine H Chung; Bettie M Steinberg; David L Schwartz
Journal:  Head Neck       Date:  2012-01-27       Impact factor: 3.147

2.  Staging for Head and Neck Cancer: Purpose, Process and Progress.

Authors:  Jatin P Shah
Journal:  Indian J Surg Oncol       Date:  2018-02-05

Review 3.  Critical Changes in the Staging of Head and Neck Cancer.

Authors:  Christine M Glastonbury
Journal:  Radiol Imaging Cancer       Date:  2020-01-31

4.  A population-based validation study of the 8th edition UICC/AJCC TNM staging system for cutaneous melanoma.

Authors:  Matthew C Hynes; Paul Nguyen; Patti A Groome; Yuka Asai; Meaghan E Mavor; Tara D Baetz; Timothy P Hanna
Journal:  BMC Cancer       Date:  2022-07-01       Impact factor: 4.638

5.  Lasso tree for cancer staging with survival data.

Authors:  Yunzhi Lin; Sijian Wang; Richard J Chappell
Journal:  Biostatistics       Date:  2012-12-05       Impact factor: 5.899

6.  A systematic selection method for the development of cancer staging systems.

Authors:  Yunzhi Lin; Richard Chappell; Mithat Gönen
Journal:  Stat Methods Med Res       Date:  2013-05-22       Impact factor: 3.021

7.  Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.

Authors:  Kristina R Dahlstrom; Adam S Garden; William N William; Ming Yann Lim; Erich M Sturgis
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544

8.  A different entity: a population based study of characteristics and recurrence patterns in oropharyngeal squamous cell carcinomas.

Authors:  Scott Murray; Michael N Ha; Kara Thompson; Robert D Hart; Murali Rajaraman; Stephanie L Snow
Journal:  J Otolaryngol Head Neck Surg       Date:  2015-08-28

9.  Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer.

Authors:  Claus Wittekindt; Steffen Wagner; Christina Sabine Mayer; Jens Peter Klussmann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20

10.  Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century.

Authors:  Adam S Garden; Merrill S Kies; William H Morrison; Randal S Weber; Steven J Frank; Bonnie S Glisson; Gary B Gunn; Beth M Beadle; K Kian Ang; David I Rosenthal; Erich M Sturgis
Journal:  Radiat Oncol       Date:  2013-01-29       Impact factor: 3.481

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.